Biotech Amgen posts Q2 net rise on higher sales of Enbrel, newer drugs, raises 2015 forecast
July 30, 2015 at 16:02 PM EDT
Higher sales of Amgen's blockbuster rheumatoid arthritis drug Enbrel and some newer drugs boosted second-quarter profit 7 percent.